Insider trading

Period: 120 months Stock: ALEC Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

108 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

108 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

108 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

108 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
108 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
108 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

108 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
4 Sep 2026
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$9.09K 3,625 at 2.51
3.3%
Not planned
3 Sep 2026
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$13.77K 5,165 at 2.67
4.5%
Not planned
2 Sep 2026
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$1.80K 656 at 2.75
0.6%
Not planned
3 Jun 2026
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$6.54K 3,475 at 1.88
3.5%
Not planned
2 Jun 2026
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$11.27K 5,709 at 1.97
5.5%
Not planned
16 Apr 2026
Wong-Sarad Grace Principal Accounting Officer
Sold on a plan
$4.82K 1,820 at 2.65
1.7%
Planned (10b5-1)
10 Mar 2026
Wong-Sarad Grace Principal Accounting Officer
Sold on a plan
$2.65K 1,000 at 2.65
0.9%
Planned (10b5-1)
3 Mar 2026
Wong-Sarad Grace Principal Accounting Officer
Sold on a plan
$7.01K 3,367 at 2.08
3.0%
Planned (10b5-1)
2 Mar 2026
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$17.14K 8,071 at 2.12
6.8%
Not planned
26 Feb 2026
Wong-Sarad Grace Principal Accounting Officer
Sold on a plan
$10.20K 4,079 at 2.50
3.3%
Planned (10b5-1)
5 Dec 2025
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$5.75K 4,753 at 1.21
3.7%
Not planned
3 Dec 2025
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$46.67K 41,687 at 1.12
7.7%
Not planned
3 Dec 2025
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$9.02K 8,056 at 1.12
5.9%
Not planned
2 Sep 2025
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$59.02K 23,638 at 2.50
4.2%
Not planned
2 Sep 2025
Berkley Neil Lindsay Principal Financial Officer
Sold at will
$39.55K 15,842 at 2.50
4.4%
Not planned
2 Sep 2025
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$14.76K 5,910 at 2.50
5.4%
Not planned
2 Jun 2025
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$31.97K 23,890 at 1.34
4.5%
Not planned
3 Mar 2025
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$42.66K 29,073 at 1.47
5.1%
Not planned
3 Mar 2025
Romano Gary Chief Medical Officer
Sold at will
$23.93K 16,306 at 1.47
4.7%
Not planned
2 Dec 2024
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$66.76K 26,500 at 2.52
4.5%
Not planned
2 Dec 2024
Romano Gary Chief Medical Officer
Sold at will
$37.52K 14,892 at 2.52
4.1%
Not planned
3 Sep 2024
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$67.98K 13,926 at 4.88
4.6%
Not planned
3 Sep 2024
Romano Gary Chief Medical Officer
Sold at will
$41.39K 8,478 at 4.88
4.5%
Not planned
3 Jun 2024
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$63.37K 13,206 at 4.80
4.1%
Not planned
3 Jun 2024
Romano Gary Chief Medical Officer
Sold at will
$38.58K 8,040 at 4.80
4.1%
Not planned
4 Mar 2024
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$70.39K 10,169 at 6.92
3.1%
Not planned
4 Mar 2024
Romano Gary Chief Medical Officer
Sold at will
$41.55K 6,001 at 6.92
3.0%
Not planned
4 Dec 2023
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$69.61K 12,519 at 5.56
3.7%
Not planned
4 Dec 2023
Romano Gary Chief Medical Officer
Sold at will
$27.99K 5,035 at 5.56
2.4%
Not planned
5 Sep 2023
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$32.28K 6,214 at 5.19
3.4%
Not planned
5 Sep 2023
Romano Gary Chief Medical Officer
Sold at will
$14.39K 2,771 at 5.19
2.7%
Not planned
2 Jun 2023
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$28.25K 4,092 at 6.90
2.2%
Not planned
2 Jun 2023
Romano Gary Chief Medical Officer
Sold at will
$18.07K 2,617 at 6.90
2.5%
Not planned
2 Mar 2023
Kenkare-Mitra Sara President and Head of R&D
Sold, plan not stated
$84.22K 10,124 at 8.32
5.1%
2 Mar 2023
Romano Gary Chief Medical Officer
Sold, plan not stated
$26.93K 3,238 at 8.32
3.0%
2 Dec 2022
Romano Gary Chief Medical Officer
Sold, plan not stated
$18.68K 2,145 at 8.71
1.9%
2 Sep 2022
Romano Gary Chief Medical Officer
Sold, plan not stated
$23.12K 2,177 at 10.62
2.4%
2 Sep 2022
King Robert Chief Development Officer
Sold, plan not stated
$1.87K 176 at 10.62
0.0%
2 Jun 2022
King Robert Chief Development Officer
Sold, plan not stated
$1.54K 177 at 8.71
0.0%
1 Mar 2022
King Robert Chief Development Officer
Sold, plan not stated
$4.47K 287 at 15.57
0.1%
13 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.59M 75,000 at 21.24
42.2%
10 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.63M 75,000 at 21.76
42.2%
9 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.71M 75,000 at 22.82
42.2%
8 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.71M 75,000 at 22.79
42.2%
1 Dec 2021
King Robert Chief Development Officer
Sold, plan not stated
$5.02K 250 at 20.09
0.0%
9 Aug 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 2×
$623.77K 22,950 at 27.18
8.9%
7 Jul 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 3×
$1.15M 29,749 at 38.70
11.3%
6 Jul 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 6×
$1.12M 30,000 at 37.31
11.3%
6 Jul 2021
Yu Calvin Vice President, Finance
Sold, plan not stated
$115.52K 3,334 at 34.65
4.2%
2 Jul 2021
Yu Calvin Vice President, Finance
Sold, plan not stated 2×
$3.63M 110,840 at 32.74
59.1%
Sold half or more
Showing 1–50 of 108. Page 1 of 3 Older →